HEALTHCARE UTILIZATION AND COSTS IN PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENTS TREATED WITH ENDOTHELIN RECEPTOR ANTAGONISTS (ERAS) OR PHOSPHODIESTERASE TYPE 5 INHIBITORS (PDE5IS)

被引：0
|
作者：
Hill, J. [1 ]
Lickert, C. [2 ]
Cole, M. [2 ]
McGuiness, K. [1 ]
Wade, R. L. [1 ]
Drake, W. [2 ]
机构：
[1] QuintielsIMS, Plymouth Meeting, PA USA
[2] Actelion Pharmaceut Inc, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV10
引用
下载
收藏
页码：A260 / A260
页数：1
相关论文
共 50 条
  • [21] Pulmonary Arterial Hypertension: Rapid Sequential Combination Therapy With PDE5 Inhibitors and Endothelin Receptor Antagonists Substantially Improves Hemodynamics at Early Follow-Up
    Kramer, Tilmann T.
    Dumitrescu, Daniel
    Gerhardt, Felix
    Nattmann, Phillip
    Hohmann, Christopher
    Baldus, Stephan
    Rosenkranz, Stephan
    CIRCULATION, 2018, 138
  • [22] Pulmonary Arterial Hypertension: Rapid Sequential Combination Therapy With PDE5 Inhibitors and Endothelin Receptor Antagonists Substantially Improves Hemodynamics at Early Follow-up
    Kramer, Tilmann T.
    Dumitrescu, Daniel
    Gerhardt, Felix
    Nattmann, Phillip
    Hohmann, Christopher
    Baldus, Stephan
    Rosenkranz, Stephan
    CIRCULATION, 2019, 140
  • [23] Rationale And Design Of The Replace Trial: Riociguat Replacing Phosphodiesterase 5 Inhibitor (pde5i) Therapy Evaluated Against Continued Pde5i Therapy In Patients With Pulmonary Arterial Hypertension (pah)
    Hoeper, M. M.
    Ghofrani, H. -A.
    Benza, R. L.
    Corris, P. A.
    Gibbs, S.
    Klinger, J. R.
    Langleben, D.
    McLaughlin, V. V.
    Peacock, A.
    Rosenkranz, S.
    Vonk-Noordegraaf, A.
    White, J.
    Kleinjung, F.
    Meier, C.
    Simonneau, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [24] Endothelin receptor (ETR) blockade combined with phosphodiesterase-5 (PDE5) inhibition prevents right ventricular hypoxia in Pulmonary Hypertension
    Mouchaers, Koen Thijs Bert
    Wong, Yeun-Ying
    Schalij, Ingrid
    Jaspers, Richard T.
    Amerongen, Geerten P. van Nieuw
    Vonk-Noordegraaf, Anton
    van der Laarse, Willem J.
    FASEB JOURNAL, 2008, 22
  • [25] Combination therapy with macitentan and phosphodiesterase type-5 inhibitor (PDE5i) in pulmonary arterial hypertension (PAH): real-world data from OPUS and OrPHeUS
    McLaughlin, V
    Channick, R.
    Kim, N. H.
    Flynn, M.
    Leroy, S.
    Wetherill, G.
    Chin, K.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2297 - 2297
  • [26] Phosphodiesterase 5 (pde5) Inhibitors Potentiate Ut-15c (treprostinil)-Mediated Increases In Both Camp And Atp Release From Erythrocytes Of Humans With Pulmonary Arterial Hypertension (pah)
    Yeragunta, Y.
    Moody, G. N.
    Bowles, E.
    Sprague, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] Rationale and Study Design of the RESPITE Trial: Riociguat Clinical Effects Studied in Pulmonary Arterial Hypertension (PAH) Patients With Insufficient Treatment Response to PDE-5 Inhibitors (PDE-5i)
    Hoeper, Marius
    Benza, Raymond
    Klinger, James
    Simonneau, Gerald
    Langleben, David
    Naeije, Robert
    Corris, Paul
    CHEST, 2015, 148 (04)
  • [28] Rationale and study design of the RESPITE trial: Riociguat clinical effects studied in pulmonary arterial hypertension (PAH) patients with insufficient treatment response to PDE-5 inhibitors (PDE-5i)
    Hoeper, Marius
    Benza, Raymond
    Simonneau, Gerald
    Klinger, James
    Langleben, David
    Naeije, Robert
    Corris, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [29] RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
    Hoeper, Marius M.
    Simonneau, Gerald
    Corris, Paul A.
    Ghofrani, Hossein-Ardeschir
    Klinger, James R.
    Langleben, David
    Naeije, Robert
    Jansa, Pavel
    Rosenkranz, Stephan
    Scelsi, Laura
    Gruenig, Ekkehard
    Vizza, Carmine Dario
    Chang, MiKyung
    Colorado, Pablo
    Meier, Christian
    Busse, Dennis
    Benza, Raymond L.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (03)
  • [30] ARTERIAL METHEMOGLOBIN LEVEL PREDICTS THERAPEUTIC EFFECTIVENESS OF THE PDE-5 INHIBITORS IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
    Ono, Tomohiko
    Tamura, Yuichi
    Kawakami, Takashi
    Kataoka, Masaharu
    Sano, Motoaki
    Satoh, Toru
    Fukuda, Keiichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1462 - E1462
12345